HG 030
Alternative Names: HG-030Latest Information Update: 22 Sep 2022
At a glance
- Originator HitGen
- Class Antineoplastics; Small molecules
- Mechanism of Action ROS1 protein inhibitors; Tropomyosin-related kinase antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Solid tumours